NMES for Achilles Tendon Rupture
Launched by PENN STATE UNIVERSITY · Jan 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people recover from an Achilles tendon rupture, which is a serious injury that can make it hard to walk or be active. The study will test a rehabilitation method that uses Neuromuscular Electrical Stimulation (NMES) to help reduce muscle loss and improve how the tendon heals. If this method proves to be helpful, it could become a regular part of treatment for this type of injury.
To participate in the trial, you need to have an Achilles tendon rupture and be between the ages of 65 and 74. Unfortunately, if you have certain health conditions, like diabetes or heart problems, or if you received a specific type of treatment for your injury, you may not be eligible. If you join the study, you can expect to follow the new rehabilitation protocol and help researchers understand its effectiveness. This is an exciting opportunity to contribute to better care for Achilles tendon injuries!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Achilles tendon rupture
- Exclusion Criteria:
- • 1. Those unable to understand spoken English.
- • 2. Participants treated non-operatively
- • 3. Augmented surgical repair (i.e., use of additional tissue at the repair site)
- • 4. Tendon ruptures associated with the use of fluoroquinolones (Examples include ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), and ofloxacin (Floxin))
- • 5. Allergy to ultrasound gel
- • 6. Any other condition affecting the ability of the participant to walk or jump
- • 7. Any other health conditions known to impair normal healing: Diabetes, Cardiovascular conditions decreasing blood supply to the leg
- • 8. Those unable to consent
About Penn State University
Penn State University is a leading research institution renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical trials. As a prominent sponsor of clinical research, the university leverages its diverse expertise across various medical fields to conduct rigorous studies aimed at evaluating new treatments, interventions, and healthcare strategies. With a strong emphasis on collaboration, ethical standards, and patient safety, Penn State University is dedicated to translating research findings into real-world applications that enhance the well-being of communities and contribute to the broader scientific landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hershey, Pennsylvania, United States
State College, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials